Kichi, Z.A.; Natarelli, L.; Sadeghian, S.; Boroumand, M.a.; Behmanesh, M.; Weber, C.
Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients. Biomedicines 2022, 10, 1736.
https://doi.org/10.3390/biomedicines10071736
AMA Style
Kichi ZA, Natarelli L, Sadeghian S, Boroumand Ma, Behmanesh M, Weber C.
Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients. Biomedicines. 2022; 10(7):1736.
https://doi.org/10.3390/biomedicines10071736
Chicago/Turabian Style
Kichi, Zahra Abedi, Lucia Natarelli, Saeed Sadeghian, Mohammad ali Boroumand, Mehrdad Behmanesh, and Christian Weber.
2022. "Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients" Biomedicines 10, no. 7: 1736.
https://doi.org/10.3390/biomedicines10071736
APA Style
Kichi, Z. A., Natarelli, L., Sadeghian, S., Boroumand, M. a., Behmanesh, M., & Weber, C.
(2022). Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients. Biomedicines, 10(7), 1736.
https://doi.org/10.3390/biomedicines10071736